Archive - The Microdose

New Top Discussion

Allbee discusses Oregon Psilocybin Services' work over the last two years, and what to expect in the coming months as OPS implements Measure 109.

2 hr ago

Plus: Barriers to vets seeking psychedelic-assisted therapy, and 2022 in review

Jan 27

Evans discusses the Challenging Psychedelic Experiences Project and what he and his co-researchers hope to learn from the data they collect.

Jan 23

Plus: Results from psychedelic brain imaging feasibility study and gaining clarity on perennial psychedelic research issues

Jan 20

Whiteman discusses how insects’ behavior may have given rise to plants and fungi with psychoactive properties.

Jan 17

Plus: Psilocybin and depression, Oregon, and Prince Harry

Jan 13

Pickard discusses his research, and how the psychedelics world has changed over his lifetime.

Jan 10

Plus: Quebec pays for psilocybin therapy, and Indigenous ethical principles to guide Western psychedelic research

Jan 6

December 2022

Mycoskie on his psychedelic philanthropy and investments, and what he hopes that accomplishes.

Dec 19, 2022

Plus: Boom and busts of shroom stores and Health Canada releases guidance on psychedelic trials

Dec 16, 2022

Priest discusses his organization Ligare and the role of religion in psychedelics.

Dec 12, 2022

Plus: DEA releases final 2023 drug quotas and Berkeley resolution could decriminalize psychedelics

Dec 9, 2022

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts